NB-LEVETIRACETAM DIN 02569434
Health Canada record
| Active ingredient(s) | LEVETIRACETAM 500 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N03AX14 LEVETIRACETAM |
| Original market date | |
| Current status date | 23-Jun-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
NB Pharma Inc. — licence 3-002798, currently licensed, last inspection rating C (2025-12-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LEVETIRACETAM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02285932 | APO-LEVETIRACETAM | APOTEX INC | Tablet | LEVETIRACETAM 500 MG | Marketed |
| 02285924 | APO-LEVETIRACETAM | APOTEX INC | Tablet | LEVETIRACETAM 250 MG | Marketed |
| 02285940 | APO-LEVETIRACETAM | APOTEX INC | Tablet | LEVETIRACETAM 750 MG | Marketed |
| 02375249 | AURO-LEVETIRACETAM | AURO PHARMA INC | Tablet | LEVETIRACETAM 250 MG | Marketed |
| 02375257 | AURO-LEVETIRACETAM | AURO PHARMA INC | Tablet | LEVETIRACETAM 500 MG | Marketed |
| 02375265 | AURO-LEVETIRACETAM | AURO PHARMA INC | Tablet | LEVETIRACETAM 750 MG | Marketed |
| 02571234 | JAMP LEVETIRACETAM SOLUTION | JAMP PHARMA CORPORATION | Solution | LEVETIRACETAM 100 MG | Approved |
| 02504553 | JAMP LEVETIRACETAM TABLETS | JAMP PHARMA CORPORATION | Tablet | LEVETIRACETAM 250 MG | Marketed |
| 02504588 | JAMP LEVETIRACETAM TABLETS | JAMP PHARMA CORPORATION | Tablet | LEVETIRACETAM 750 MG | Marketed |
| 02247029 | KEPPRA | UCB CANADA INC | Tablet | LEVETIRACETAM 750 MG | Marketed |
| 02247028 | KEPPRA | UCB CANADA INC | Tablet | LEVETIRACETAM 500 MG | Marketed |
| 02353342 | LEVETIRACETAM | SANIS HEALTH INC | Tablet | LEVETIRACETAM 250 MG | Marketed |
| 02407175 | LEVETIRACETAM | JUBILANT GENERICS LIMITED | Tablet | LEVETIRACETAM 750 MG | Approved |
| 02353369 | LEVETIRACETAM | SANIS HEALTH INC | Tablet | LEVETIRACETAM 750 MG | Marketed |
| 02564734 | LEVETIRACETAM FOR INJECTION | SANDOZ CANADA INCORPORATED | Solution | LEVETIRACETAM 100 MG | Approved |
| 02527375 | LEVETIRACETAM INJECTION USP | STERIMAX INC | Solution | LEVETIRACETAM 100 MG | Marketed |
| 02442396 | MINT-LEVETIRACETAM | MINT PHARMACEUTICALS INC | Tablet | LEVETIRACETAM 500 MG | Marketed |
| 02442388 | MINT-LEVETIRACETAM | MINT PHARMACEUTICALS INC | Tablet | LEVETIRACETAM 250 MG | Marketed |
| 02558416 | MINT-LEVETIRACETAM SOLUTION | MINT PHARMACEUTICALS INC | Solution | LEVETIRACETAM 100 MG | Marketed |
| 02569442 | NB-LEVETIRACETAM | NB PHARMA INC. | Tablet | LEVETIRACETAM 750 MG | Approved |
| 02569450 | NB-LEVETIRACETAM | NB PHARMA INC. | Tablet | LEVETIRACETAM 1000 MG | Approved |
| 02569426 | NB-LEVETIRACETAM | NB PHARMA INC. | Tablet | LEVETIRACETAM 250 MG | Approved |
| 02490439 | PDP-LEVETIRACETAM | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Solution | LEVETIRACETAM 100 MG | Marketed |
| 02490447 | PDP-LEVETIRACETAM | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Solution | LEVETIRACETAM 100 MG | Marketed |
| 02296128 | PMS-LEVETIRACETAM | PHARMASCIENCE INC | Tablet | LEVETIRACETAM 500 MG | Marketed |
| 02296101 | PMS-LEVETIRACETAM | PHARMASCIENCE INC | Tablet | LEVETIRACETAM 250 MG | Marketed |
| 02296136 | PMS-LEVETIRACETAM | PHARMASCIENCE INC | Tablet | LEVETIRACETAM 750 MG | Marketed |
| 02311372 | PRO-LEVETIRACETAM - 250 | PRO DOC LIMITEE | Tablet | LEVETIRACETAM 250 MG | Marketed |
| 02311380 | PRO-LEVETIRACETAM - 500 | PRO DOC LIMITEE | Tablet | LEVETIRACETAM 500 MG | Marketed |
| 02461994 | SANDOZ LEVETIRACETAM | SANDOZ CANADA INCORPORATED | Tablet | LEVETIRACETAM 500 MG | Marketed |
| 02462001 | SANDOZ LEVETIRACETAM | SANDOZ CANADA INCORPORATED | Tablet | LEVETIRACETAM 750 MG | Marketed |
| 02462028 | SANDOZ LEVETIRACETAM | SANDOZ CANADA INCORPORATED | Tablet | LEVETIRACETAM 1000 MG | Marketed |
| 02461986 | SANDOZ LEVETIRACETAM | SANDOZ CANADA INCORPORATED | Tablet | LEVETIRACETAM 250 MG | Marketed |
| 02274205 | TEVA-LEVETIRACETAM | TEVA CANADA LIMITED | Tablet | LEVETIRACETAM 750 MG | Marketed |
| 02274191 | TEVA-LEVETIRACETAM | TEVA CANADA LIMITED | Tablet | LEVETIRACETAM 500 MG | Marketed |
| 02274183 | TEVA-LEVETIRACETAM | TEVA CANADA LIMITED | Tablet | LEVETIRACETAM 250 MG | Marketed |
| 02414783 | ABBOTT-LEVETIRACETAM | ABBOTT LABORATORIES, LIMITED | Tablet | LEVETIRACETAM 750 MG | Cancelled Post Market |
| 02399792 | ACH-LEVETIRACETAM | ACCORD HEALTHCARE INC | Tablet | LEVETIRACETAM 750 MG | Dormant |
| 02399784 | ACH-LEVETIRACETAM | ACCORD HEALTHCARE INC | Tablet | LEVETIRACETAM 500 MG | Dormant |
| 02399776 | ACH-LEVETIRACETAM | ACCORD HEALTHCARE INC | Tablet | LEVETIRACETAM 250 MG | Dormant |
| 02371677 | AVA-LEVETIRACETAM | AVANSTRA INC | Tablet | LEVETIRACETAM 250 MG | Cancelled Post Market |
| 02371693 | AVA-LEVETIRACETAM | AVANSTRA INC | Tablet | LEVETIRACETAM 750 MG | Cancelled Post Market |
| 02371685 | AVA-LEVETIRACETAM | AVANSTRA INC | Tablet | LEVETIRACETAM 500 MG | Cancelled Post Market |
| 02450348 | BIO-LEVETIRACETAM | BIOMED PHARMA | Tablet | LEVETIRACETAM 250 MG | Cancelled Post Market |
| 02297396 | DOM-LEVETIRACETAM | DOMINION PHARMACAL | Tablet | LEVETIRACETAM 250 MG | Cancelled Post Market |
| 02297418 | DOM-LEVETIRACETAM | DOMINION PHARMACAL | Tablet | LEVETIRACETAM 500 MG | Cancelled Post Market |
| 02403005 | JAMP-LEVETIRACETAM | JAMP PHARMA CORPORATION | Tablet | LEVETIRACETAM 250 MG | Dormant |
| 02343649 | LEVETIRACETAM | COBALT PHARMACEUTICALS COMPANY | Tablet | LEVETIRACETAM 750 MG | Cancelled Pre Market |
| 02343622 | LEVETIRACETAM | COBALT PHARMACEUTICALS COMPANY | Tablet | LEVETIRACETAM 250 MG | Cancelled Pre Market |
| 02310724 | NOVO-LEVETIRACETAM | NOVOPHARM LIMITED | Tablet | LEVETIRACETAM 750 MG | Cancelled Pre Market |
| 02336251 | NU-LEVETIRACETAM | NU-PHARM INC | Tablet | LEVETIRACETAM 250 MG | Cancelled (Unreturned Annual) |
| 02336286 | NU-LEVETIRACETAM | NU-PHARM INC | Tablet | LEVETIRACETAM 750 MG | Cancelled (Unreturned Annual) |
| 02336278 | NU-LEVETIRACETAM | NU-PHARM INC | Tablet | LEVETIRACETAM 500 MG | Cancelled (Unreturned Annual) |
| 02297361 | PHL-LEVETIRACETAM | PHARMEL INC | Tablet | LEVETIRACETAM 500 MG | Cancelled Post Market |
| 02297353 | PHL-LEVETIRACETAM | PHARMEL INC | Tablet | LEVETIRACETAM 250 MG | Cancelled Post Market |
| 02450372 | PRIVA-LEVETIRACETAM | PHARMAPAR INC | Tablet | LEVETIRACETAM 250 MG | Cancelled Pre Market |
| 02450399 | PRIVA-LEVETIRACETAM | PHARMAPAR INC | Tablet | LEVETIRACETAM 750 MG | Cancelled Pre Market |
| 02396122 | RAN-LEVETIRACETAM | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | LEVETIRACETAM 750 MG | Cancelled Post Market |
| 02396106 | RAN-LEVETIRACETAM | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | LEVETIRACETAM 250 MG | Cancelled Post Market |
| 02432374 | VAN-LEVETIRACETAM | VANC PHARMACEUTICALS INC | Tablet | LEVETIRACETAM 250 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37757 | 2026-06-23 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement between two manufacturers |
International API supply for LEVETIRACETAM
30 valid EDQM Certificates of Suitability from 28 holders. 31 active FDA Drug Master Files.
Request a quote for NB-LEVETIRACETAM